Red Tree Management’s Bicara Therapeutics BCAX Stock Holding History

Red Tree Management’s Portfolio BCAX Stock Details BCAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$54.4M	Sell	2,920,509 -243,008	-8%	-$6.08M	46.57%	1
2026 Q2	$93.9M	Sell	3,163,517 -6,992	-0.2%	-$156K	63.77%	1
2026 Q1	$63.1M	Hold	3,170,509	–	–	56.39%	1
2025 Q4	$53.4M	Hold	3,170,509	–	–	48.94%	1
2025 Q3	$50.1M	Hold	3,170,509	–	–	60.39%	1
2025 Q2	$29.5M	Hold	3,170,509	–	–	40.18%	2
2025 Q1	$41.3M	Hold	3,170,509	–	–	44.61%	2
2024 Q4	$55.2M	Buy	+3,170,509	New	+$66M	36.35%	2

Other funds holding BCAX

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Private Trust Company Cleveland, Ohio $1.27B AUM 20.99% 1-Year Est. Return

Red Tree Management's BCAX Position: Q3 2026 in Review

Red Tree Management reduced its Bicara Therapeutics (BCAX) stake by 7.7% in Q3 2026, selling an estimated $6.08M and leaving 2,920,509 shares worth $54.4M. The position accounts for 46.57% of the portfolio, ranked #1.

Red Tree Management first reported a position in BCAX in Q4 2024 and has held it in 8 quarters since. The position peaked at $93.9M in Q2 2026. 20 funds tracked by Wall St. Rank hold BCAX as of Q3 2026.

Red Tree Management held 2,920,509 shares of Bicara Therapeutics worth $54.4M as of Q3 2026.
Red Tree Management sold 243,008 Bicara Therapeutics shares in Q3 2026, an estimated $6.08M.
Bicara Therapeutics made up 46.57% of Red Tree Management's portfolio in Q3 2026, its #1 holding.
Red Tree Management first reported a position in Bicara Therapeutics in Q4 2024 and has held it in 8 quarters since.
Red Tree Management's Bicara Therapeutics position peaked at $93.9M in Q2 2026.
20 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q3 2026.

Based on Red Tree Management's 13F filing for Q3 2026, filed 15 Oct 2026.